Nano, I've been trying to find who to bet on now that share prices are very low. At some points companies could be picked up at 20% of (adjusted) book value. No matter how I twist and turn things I get SOL as an extremely clear candidate and then nothing. Far, far behind there's been other companies that seem to be structured for some profitability in a low ASP world, like JKS, CSIQ, HSOL, JASO, but there's always been some issues with them. I need to find 1-3 other solars to complement my SOL position.
Right now I think you'll be happy to hear that CSIQ is the best runner-up candidate and that is based on that I think they are best positioned for 2013-2014. Here's my view on CSIQ.
Strengths:
- Sales efficiency. Can channel modules flexibly at low organisational overhead cost.
- Module processing. Have focus on automation and it looks like they are ahead of competition.
- Downstream pipeline. Have a pipeline of projects with great projected margin. Not huge, since they only do small project, but still many projects at high return to have and interesting risk/reward pipeline at respectable size. Continued success here is uncertain though.
- Procurement. The seem to be able to get raw material at prevailing market prices.
- Taking the emerging and lucrative markets.
- Low opex and interest per watt.
Weaknesses:
- Wafer manufacturing. Not good at this so far, leaves them no choice but to outsource much of this and give up the margins for this vertical from the modules they sell. This is a major difference compared to YGE for example.
- Cell manufacturing. Have a lot of capacity here, but it seems less cost efficient than peers, again inferior to YGE.
- Naive (or sneaky?) management? Management kept talking about being able to secure fixed price wafer constracts at prices where GCL would lose money, like they thought 2012 price developement was a normalized cost based development. It should be quite basic economics that, over time, the more you've made yourself of the product you are selling, the more profits from that sale end up in your own pocket. You cannot claim the profits for values added in parts of the chain where you've not contributed.
Uncertain:
- Product quality. Can they do premium products at low cost? ELPS was only a 5MW for a long time, but now they're ramping ELPS to 120MW. I see this as a chance that CSIQ have a chance to become a player with premium products in mass production mode. Still something stranges with ELPS. 21% cell efficiency only results in 16.5% module efficiency (similar to SOL, JASO and YGE mono offers).
The last point is important for me. The way I see it is CSIQ is a work in progress to make their own and not GCL's fortune. In the mean-time they can improve their war chest more than others in 2013-2014, thanks to their perfect timing on betting downstream instead of upstream. Over time I think it is easier to collect profits from being best of best upstream provider than fighting in crowded downstream segments. Full end-to-end vertical integration where you are the best in several parts of the value-chain is the ideal structure for me though, to reduce supply-chain management and carrying cost subjected to market price fluctuations (it seems that can eat all you accumulated earnings in this industry), besides the benefit of collecting the gross profits from each vertical to cover your opex and interest.
The reason that SOL is a clear choice is that after 5 years they've reach a very strong poly position. The 6kT their adding now will have a 16 $/kg cost and very low interest on top of that due to record low capex per kg. That's a very low cost for a relatively small scale. From here they can just expand that. This is a strength that took 5 years to build. On wafers, they've spent a lot of R&D and are now in a position where they can make the best wafers at the lowest cost. Having the best stuff in-house to power their modules have led them to easily take module market-shares from a position of nothing. In Q4 the are growing their module shipments with 80% from Q3. The are also (like CSIQ) free from high SG&A and interest cost and from large purchase commitments.